Register
Question 1
What type of study involves data collectors abstracting the same charts to review coding consistency?
Correct Answer:
Reliability study.
Explanation:
The correct answer is a reliability study. In this context, the focus is on assessing the consistency and accuracy of data collected from patient charts. Reliability studies are designed to determine how consistently two or more data collectors apply coding criteria when abstracting the same set of charts. This helps to identify any discrepancies in data collection practices and ensures that the information being gathered is reliable and valid. In a reliability study, the data collectors will independently review the same charts and compare their findings to see if they have reached the same conclusions consistently. If variations occur, this could indicate a need for further training or adjustments in coding guidelines to ensure uniformity. The term "reabstracting study" generally refers to a specific type of reliability study where the same data is abstracted a second time, often to validate the initial results. However, the core focus of the reliability study is more general, encompassing the idea of examining the consistency between coders. Thus, it can be concluded that while a reabstracting study is a form of a reliability study, the essence of the question pertains to reliability itself. This clarity helps to reinforce the importance of maintaining high standards in data abstraction processes in cancer registries, ensuring that the information used for research and treatment planning is trustworthy.
Question 2
What is an important patient data field that is NOT typically included in basic patient information?
Correct Answer:
Medical history
Explanation:
The correct answer regarding an important patient data field that is not typically included in basic patient information is medical history. While medical history is essential for understanding a patient's overall health and treatment background, it is often considered a more complex component of a patient's record that goes beyond the basic demographic and clinical information usually captured at the outset, such as the patient's diagnosis, relevant tumor characteristics, and personal identification details. Basic patient information typically includes items like the diagnosis date, histology, and social security number, which are directly related to the patient's cancer treatment and administrative processes. These elements are crucial for proper tumor registration and tracking patient outcomes, while medical history may be documented in a separate section and may require more in-depth clinical review to compile effectively. Therefore, it is generally not classified as a part of the basic patient information set commonly used in cancer registry data collection.
Question 3
Which type of cancer treatment specifically alters the immune system?
Correct Answer:
Biologic response modifiers
Explanation:
The option that specifically alters the immune system is biologic response modifiers. These treatments are designed to enhance or restore the immune system's ability to fight cancer. They can work by stimulating the immune system directly or by creating a more favorable environment for the immune cells to effectively target and destroy cancer cells. Biologic response modifiers include a variety of agents such as monoclonal antibodies, cytokines, and vaccines, which can specifically activate immune cells or modulate immune pathways to improve the body’s response to cancer. This approach is distinct from other treatment modalities, which do not primarily focus on modifying the immune response. Hormonal therapy focuses on interfering with hormone signals that can promote the growth of certain cancers, particularly hormone-sensitive cancers like breast and prostate cancer. Radiation therapy utilizes high-energy particles or waves to destroy or damage cancer cells, but does not have a direct effect on the immune system. Surgery involves the physical removal of tumors or affected tissues and does not modulate immune function directly. Therefore, biologic response modifiers are uniquely positioned as treatments that specifically target and alter the immune system to combat cancer.
Question 4
What practice ensures that only proper codes are used in data fields?
Correct Answer:
Range edit check
Explanation:
The concept that ensures only proper codes are used in data fields is rooted in the practice of range edit checks. Range edit checks involve establishing parameters or a predefined set of criteria that the data must adhere to. This process helps identify any coding errors or values that fall outside of expected ranges. In the context of tumor registries and cancer data, it is crucial that the codes entered for diagnoses, treatments, or outcomes conform to established coding standards. Range edit checks can effectively flag any discrepancies by validating that the codes used fall within acceptable limits or categories, thereby ensuring the integrity of the data. While data normalization, data validation, and quality assurance are related concepts aimed at improving the accuracy and reliability of data, they do not specifically focus on limiting the codes to only those that are appropriate for data fields in the same targeted way that range edit checks do. Data validation checks the accuracy and legitimacy of data entries, but may not directly limit them to a specific range of acceptable codes, while quality assurance encompasses a broader scope of practices intended to maintain overall data quality.
Question 5
Which procedure is primarily used to ensure data completeness?
Correct Answer:
Reabstracting studies
Explanation:
The correct procedure used to ensure data completeness is reabstracting studies. This method involves taking previously abstracted data and having another trained abstractor independently perform the abstraction process again using the original source documents. The primary goal is to compare the two sets of data for discrepancies and determine the completeness of the data collected. Reabstracting studies specifically help identify areas where data may have been omitted or inaccurately recorded, thereby providing insights into the thoroughness and robustness of the data collection process. By identifying and rectifying these discrepancies, organizations can enhance the quality and reliability of their cancer registry data, ensuring that all pertinent information is captured effectively. While reliability studies focus on the consistency and accuracy of data across different abstractors, and data input audits examine the accuracy of data entry processes, these methods do not specifically target the completeness of the data itself. Source document verification involves checking the information captured against the primary source documents, which is important, but it does not measure completeness in the same targeted manner as reabstracting studies do. Thus, reabstracting studies stand out as the key procedure to ensure data completeness in this context.
Question 1
Exam overview

About this Exam

The SEER Certified Tumor Registrar (CTR) Operations certification is a prestigious credential for medical data professionals who want to specialize in cancer registry.

It is designed to validate your expertise in abstracting, coding, and managing oncology data according to the strict guidelines set by the Surveillance, Epidemiology, and End Results (SEER) program.

This exam is perfect for medical records professionals, clinical data specialists, and aspiring oncology registrars who want to play a crucial role in public health and cancer research.

By passing this test, you prove that you have the meticulous attention to detail required to maintain high-quality cancer data used by researchers worldwide.

More details

Additional Information

What the Course Entails and Exam Details

Preparing for the CTR/ODS Operations exam requires a deep dive into the anatomy and physiology of the human body.

You will spend significant time learning advanced medical terminology, specifically focusing on oncology and pathology.

The coursework heavily emphasizes coding and staging cancer cases using industry-standard systems, including ICD-O, the AJCC TNM staging system, and SEER Summary Stage rules.

You will also learn the daily operations of a cancer registry, including case finding, data quality assurance, and compliance with state and national reporting standards.

Finally, candidates must master the legal, ethical, and privacy standards associated with handling sensitive patient health information.


What to Expect in the Final Exam

The final certification exam is a rigorous, computer-based test designed to challenge your theoretical knowledge and practical skills.

It is typically divided into two main sections: a closed-book section and an open-book section.

The closed-book portion consists of multiple-choice questions covering registry operations, data quality, and general medical knowledge.

The open-book portion allows you to use approved coding manuals to test your practical ability to abstract and stage complex cancer cases.

You will generally have up to four hours to complete the exam, which features around 250 multiple-choice questions.

A passing score is typically determined by a scaled scoring system, meaning you must demonstrate strong proficiency across all tested domains rather than just achieving a simple percentage.


How to Study and Exam Centers

Success on this exam requires a highly structured study plan utilizing official SEER manuals and National Cancer Registrars Association (NCRA) study guides.

You should consistently practice with mock exams to build your speed and become comfortable navigating your coding manuals under time pressure.

Many candidates benefit from joining professional study groups or taking structured online preparation courses authorized by the NCRA.

When you are ready, the official exam is administered through Pearson VUE testing centers.

You can choose to take the test at a secure, physical Pearson VUE location near you, or, in some cases, via a remotely proctored online portal from your home computer.


Job Opportunities from the Course

Certified Tumor Registrar (CTR) / Oncology Data Specialist (ODS)

Cancer Registry Manager

Clinical Data Abstractor

Oncology Research Coordinator

Public Health Data Analyst

Cancer Program Administrator

Health Information Management (HIM) Specialist


Quiz information

Frequently Asked Questions

The complete question count is available after full access is unlocked.
No fixed duration is currently configured for this quiz.
Question explanations are included where they are available in the quiz content, helping you review the reasoning after answering.
Yes. You can retake the practice test again as you continue studying during your available access period.
After your access is confirmed, you can continue into the complete practice exam from this quiz flow.
Unless explicitly stated otherwise, this page provides independent practice material for study and exam preparation and is not the official examination itself.
Keep studying

Related Questions

ISC2 Certified in Cybersecurity Practice Exam

0 min

340B Program Operations Certificate Practice Exam

0 min

Arizona CNA Certified Nursing Assistant Practice Exam

0 min

Certified Professional Public Buyer (CPPB) Practice Exam

0 min

Arizona Registrar of Contractors (AZ ROC) Practice Exam

0 min

Certified Specialist Business Intelligence (CSBI) Practice Test

0 min